Literature DB >> 2145446

Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein.

X F Yu1, M Matsuda, M Essex, T H Lee.   

Abstract

The genomes of simian immunodeficiency viruses isolated from rhesus macaques (SIVmac) contain an open reading frame (ORF), vpr, which has a coding potential of 97 to 101 amino acid residues. In this study, a vpr ORF-encoded protein of approximately 11 kDa was identified, and anti-vpr antibodies were detected in rhesus macaques infected by SIVmac. These results provide clear evidence that the vpr ORF is a coding gene of SIVmac. The vpr protein, like the vpx protein which is encoded by another accessory gene of SIVmac, was also found to be associated with viral particles. This observation demonstrates that more than one accessory gene product can be present in the virions of this family of retroviruses and raises the possibility that the vpr protein may have a role in early part of the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145446      PMCID: PMC248631     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells.

Authors:  D Dedera; W Hu; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

2.  A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.

Authors:  D M Benko; S Schwartz; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

3.  Identification of HIV-1 vpr product and function.

Authors:  E A Cohen; E F Terwilliger; Y Jalinoos; J Proulx; J G Sodroski; W A Haseltine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Mutational analysis of the human immunodeficiency virus vpr open reading frame.

Authors:  K Ogawa; R Shibata; T Kiyomasu; I Higuchi; Y Kishida; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  The human immunodeficiency virus type 2 (HIV-2) contains a novel gene encoding a 16 kD protein associated with mature virions.

Authors:  G Franchini; J R Rusche; T J O'Keeffe; F Wong-Staal
Journal:  AIDS Res Hum Retroviruses       Date:  1988-08       Impact factor: 2.205

6.  Structure of simian immunodeficiency virus regulatory genes.

Authors:  S Colombini; S K Arya; M S Reitz; L Jagodzinski; B Beaver; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM).

Authors:  R Shibata; T Miura; M Hayami; K Ogawa; H Sakai; T Kiyomasu; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1.

Authors:  X L Li; T Moudgil; H V Vinters; D D Ho
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.

Authors:  M H Malim; S Böhnlein; R Fenrick; S Y Le; J V Maizel; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  A tripartite HIV-1 tat-env-rev fusion protein.

Authors:  J Salfeld; H G Göttlinger; R A Sia; R E Park; J G Sodroski; W A Haseltine
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more
  50 in total

1.  The first HxRxG motif in simian immunodeficiency virus mac239 Vpr is crucial for G(2)/M cell cycle arrest.

Authors:  Sandra M Mueller; Sabine M Lang
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis.

Authors:  Huidong Yuan; Yi-Ming Xie; Irvin S Y Chen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

4.  Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation.

Authors:  S A Stewart; B Poon; J Y Song; I S Chen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.

Authors:  X Yu; X Yuan; Z Matsuda; T H Lee; M Essex
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

6.  Viral determinants of integration site preferences of simian immunodeficiency virus-based vectors.

Authors:  Hella Monse; Stephanie Laufs; Seraphin Kuate; W Jens Zeller; Stefan Fruehauf; Klaus Uberla
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  Regulatory genes of simian immunodeficiency viruses from west African green monkeys (Cercopithecus aethiops sabaeus).

Authors:  V Jubier-Maurin; P Sarni-Manchado; F Veas; N Vidal; F Bibollet-Ruche; J P Durand; A Galat-Luong; G Cuny
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects.

Authors:  I G Macreadie; L A Castelli; D R Hewish; A Kirkpatrick; A C Ward; A A Azad
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.

Authors:  E Kondo; F Mammano; E A Cohen; H G Göttlinger
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Increased levels of Wee-1 kinase in G(2) are necessary for Vpr- and gamma irradiation-induced G(2) arrest.

Authors:  Huidong Yuan; Masakazu Kamata; Yi-Ming Xie; Irvin S Y Chen
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.